Therapy for leukemia
作者： Mohammad Azam , Meenu Kesarwani
DOI:
关键词: Dosing regimen 、 Pharmacology 、 Tyrosine kinase 、 Medicine 、 Leukemia
摘要: A pharmaceutically acceptable composition and method for leukemia therapy in a patient need of such therapy. The contains, as the only active agents, combination (a) an inhibitor c-Fos, (b) Dusp-1, (c) BCR-ABL tyrosine kinase. is administered to dosing regimen period sufficient provide leukemia.
lens.org 参考文章(29)
Marta Aparicio, Frank Cuttitta, Enrique Zudaire, Antiangiogenic small molecules and methods of use ,(2010)
Vasiliy N. Korotchenko, Billy W. Day, Waikok Michael Tsang, Small molecule inhibitors of Dusp6 and uses therefor ,(2010)
Ru Chih C. Huang, Chih-Chuan Chang, Jonathan D. Heller, Method for treatment of tumors using nordihydroguaiaretic acid derivatives ,(2002)
Shaoguang Li, Methods and compositions relating to hematologic malignancies ,(2010)
Joseph Sparano, Carl Yoshizawa, Steve Shak, Robert Gray, Joffre B. Baker, Tests to predict responsiveness of cancer patients to chemotherapy treatment options ,(2009)
Seyed Fazel Nabavi, Maria Daglia, Akbar Hajizadeh Moghaddam, Solomon Habtemariam, Seyed Mohammad Nabavi, Curcumin and Liver Disease: from Chemistry to Medicine Comprehensive Reviews in Food Science and Food Safety. ,vol. 13, pp. 62- 77 ,(2014) , 10.1111/1541-4337.12047
T. S. Huang, S. C. Lee, J. K. Lin, Suppression of c-Jun/AP-1 activation by an inhibitor of tumor promotion in mouse fibroblast cells. Proceedings of the National Academy of Sciences of the United States of America. ,vol. 88, pp. 5292- 5296 ,(1991) , 10.1073/PNAS.88.12.5292
Seyeon Park, Dug-Keun Lee, Chul-Hak Yang, Inhibition of fos–jun–DNA complex formation by dihydroguaiaretic acid and in vitro cytotoxic effects on cancer cells Cancer Letters. ,vol. 127, pp. 23- 28 ,(1998) , 10.1016/S0304-3835(97)00543-0